NCT06031038Completed
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
Impact of Telemonitoring in the Management of Complex Inflammatory Bowel Disease in Spain: TECCU Multicenter Study
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
M-TECCU is a study: multicenter, randomized and open. It consists of two parallel groups to compare the efficacy of the TECCU web-based telemonitoring system to achieve and maintain activity remission in patients with moderate-high complexity inflammatory bowel disease compared to usual clinical practice.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 290 (actual)
- First submitted
- 24 Jul 2023
- Start date
- 15 Sept 2020
- Primary completion date
- 13 Oct 2021
- Lead sponsor
- Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06031038
What you commit to
- Study type: Interventional
- Participants enrolled: 290
- From 15 Sept 2020 to the primary completion date, 13 Oct 2021
- 30 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of active perianal disease, ileoanal reservoir, or definitive stoma
- Patients with mental illness or other poorly controlled illness
- Patients with active cancer diagnosis
Other
- Pregnant women
- Terminal patients and/or palliative care (SECPAL)
- Family members of the research team
- Patients without a telephone line to connect with a mobile, tablet and/or computer / Inability to drive
- Cognitive or linguistic difficulties
- Patients included in another experimental study
Who the study is looking for
- Patients ≥18a
- IBD (CD or UC) diagnosed according to ECCO criteria
- Start treatment with immunosuppressants and/or biological therapies due to luminal activity
- signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (30)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de Alicante Coordinator of this site? Confirm its status | Alicante | Spain | Unknown status |
| Hospital Germans Trias i Pujol Coordinator of this site? Confirm its status | Badalona | Spain | Unknown status |
| Hospital Universitario De Burgos Coordinator of this site? Confirm its status | Burgos | Spain | Unknown status |
| Hospital Universitario de Cabueñes Coordinator of this site? Confirm its status | Cabueñes | Spain | Unknown status |
| Hospital Universitario Reina Sofia Coordinator of this site? Confirm its status | Córdoba | Spain | Unknown status |
| Hospital de Cruces Coordinator of this site? Confirm its status | Cruces | Spain | Unknown status |
| Hospital General Universitario de Elche Coordinator of this site? Confirm its status | Elche | Spain | Unknown status |
| Hospital Universitario de Fuenlabrada Coordinator of this site? Confirm its status | Fuenlabrada | Spain | Unknown status |
| Hospital Trueta de Girona Coordinator of this site? Confirm its status | Girona | Spain | Unknown status |
| Hospital Universitario San Cecilio Coordinator of this site? Confirm its status | Granada | Spain | Unknown status |
| Hospital de Huelva Coordinator of this site? Confirm its status | Huelva | Spain | Unknown status |
| Hospital La Paz Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital Puerta del Hierro Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital Gregorio Marañon Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital La Princesa Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital Ramón y Cajal Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital de Manresa Coordinator of this site? Confirm its status | Manresa | Spain | Unknown status |
| Hospital Morales Meseguer Coordinator of this site? Confirm its status | Murcia | Spain | Unknown status |
| Hospital Parc Taulí de Sabadell Coordinator of this site? Confirm its status | Sabadell | Spain | Unknown status |
| Hospital Infanta Sofia Coordinator of this site? Confirm its status | San Sebastián de los Reyes | Spain | Unknown status |
| Hospital Nuestra Señora de la Candelaria Coordinator of this site? Confirm its status | Santa Cruz de Tenerife | Spain | Unknown status |
| Hospital Marques de Valdecilla Coordinator of this site? Confirm its status | Santander | Spain | Unknown status |
| Hospital Universitario de Santiago Coordinator of this site? Confirm its status | Santiago de Compostela | Spain | Unknown status |
| Hospital Universitario Mútua Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
| Consorci Sanitari de Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
| Hospital Universitario Y Politecnico La Fe Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Hospital Clinico Universitario Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Hospital de Vigo Coordinator of this site? Confirm its status | Vigo | Spain | Unknown status |
| Hospital Clinico Universitario Lozano Blesa Coordinator of this site? Confirm its status | Zaragoza | Spain | Unknown status |
| Hospital Universitario Miquel Servet Coordinator of this site? Confirm its status | Zaragoza | Spain | Unknown status |
Related publications
- The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.Clin Gastroenterol Hepatol · 2026 · PMID 42190979
This page is information, not medical advice. Discuss any trial with your doctor.